# Ketamine and Midazolam Infusions for CRPS: Feasibility Study

> **NCT05945147** · PHASE2 · WITHDRAWN · sponsor: **Stanford University**

## Conditions studied

- Complex Regional Pain Syndromes

## Interventions

- **DRUG:** Ketamine
- **DRUG:** Midazolam
- **DRUG:** Normal Saline

## Key facts

- **NCT ID:** NCT05945147
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2099-01-01
- **Primary completion:** 2099-04-30
- **Final completion:** 2099-05-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of funding
- **Last updated:** 2024-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05945147

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05945147, "Ketamine and Midazolam Infusions for CRPS: Feasibility Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05945147. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*